{"name":"Ganymed Pharmaceuticals GmbH","slug":"ganymed-pharmaceuticals-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-09-30","label":"Claudiximab Phase 3 readout (Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer)","drug":"Claudiximab","drugSlug":"claudiximab","type":"phase3_readout","sentiment":"neutral"},{"date":"2026-09-30","label":"Claudiximab Phase 3 readout (Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer)","drug":"Claudiximab","drugSlug":"claudiximab","type":"phase3_readout","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-09-30","label":"Claudiximab Phase 3 readout (Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer)","drug":"Claudiximab","drugSlug":"claudiximab","type":"phase3_readout","sentiment":"neutral"},{"date":"2031-10-27","label":"Claudiximab Phase 3 readout (Gastric Cancer, Gastroesophageal Junction Adenocarcinoma)","drug":"Claudiximab","drugSlug":"claudiximab","type":"phase3_readout","sentiment":"neutral"},{"date":"2034-01-01","label":"Claudiximab Phase 2 readout (Esophageal Cancer, Gastric (Stomach) Cancer)","drug":"Claudiximab","drugSlug":"claudiximab","type":"phase3_readout","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Claudiximab","genericName":"Claudiximab","slug":"claudiximab","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Claudiximab","genericName":"Claudiximab","slug":"claudiximab","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNcldidDh3UmNfLVNHemoxakdxRWxhWExZcnczcFd2Y3RoUDRxM3ZmWFdoR0twRnI0NzljRnlmT0xEVGh1LVpBNFYyRmJUeUJNM29idFV6eVdZTFg4bFRrZW51MTVqQkJ5aEc2RjVMUDJuNFNnbklqX0Ffa0FxNVl2d0p5WjlqYkVwSjh0WEpYMlVoZnhNdlln?oc=5","date":"2020-11-13","type":"pipeline","source":"New York Post","summary":"COVID-19 vaccine hopes have made these twins $8 billion richer - New York Post","headline":"COVID-19 vaccine hopes have made these twins $8 billion richer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQanBOZmIybG43MDluM29IVDZRc2xRSzhoMGZvXzc1ZUJ6S3NJb0dTMVpJVnhycWVYZkV5VkZnMnBlX2plNWdwSURJZjBCd0p6Rl95N25tQ2hJNi1UbHM4blVqcnEzYTV1OTB3NzMzSE5ZcXN3OHRmdlp0WHZFbDJEb2FhaFJVQm8?oc=5","date":"2016-11-02","type":"deal","source":"drugdiscoverytrends.com","summary":"Astellas to Acquire Ganymed Pharmaceuticals - drugdiscoverytrends.com","headline":"Astellas to Acquire Ganymed Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNMDI1aGhSejZ2Q2ljWHFBS3FsOWMtZTZEZU9GaV9iS1Z6T0VnWHB6dGlleDk1UFZyNXRnalF4NlZWRzJWSzIyMlVkWEUyUzZIYVozTlFrYlhldDFOX3dOOWlVQnRrdlgzQW1fZDRCMTJZVHZqS1lrRWsyYmZmb2U1WjVfZWpkTXVMRXpoRXZzYUk5SlJ2cFNIellIUTNxYnBF?oc=5","date":"2016-10-28","type":"deal","source":"PR Newswire","summary":"Astellas to Acquire Ganymed Pharmaceuticals - PR Newswire","headline":"Astellas to Acquire Ganymed Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOeXZ0MDYxQ0hvMDNHR2czdTNabVNtazExYjlTNkE0QW9ra2FrQzljTWdfckZUU3NseEFJVHM3dW0xcld2QTB0ZzhOX3VMMTJGQlBXSHhEVmNZOFh0TEN1NzNXb2JhTmMtM01lVHN4YnF2VjFQTHYxME9pYm5SbFY2ZVBHVWJsNzdnMHJHcFJoZXROdUNqZXNiRWNHSkpidw?oc=5","date":"2016-06-05","type":"pipeline","source":"Fierce Biotech","summary":"Billionaire-backed Ganymed grabs ASCO spotlight with gastric cancer drug - Fierce Biotech","headline":"Billionaire-backed Ganymed grabs ASCO spotlight with gastric cancer drug","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}